Marché de l’asparaginase – Analyse des tendances et de la croissance | Année de prévision 2031

  • Report Code : TIPRE00008224
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 176
Buy Now

Le marché de l'asparaginase devrait passer de 564,01 millions de dollars US en 2021 à 1 575,62 millions de dollars US d'ici 2028. Il devrait croître à un TCAC de 16,1 % de 2022 à 2028.  



L'asparaginase est une enzyme qui décompose l'asparagine. L'asparaginase est utilisée comme agent chimiothérapeutique pour traiter la leucémie aiguë lymphoblastique (LAL), le lymphome lymphoblastique (LBL) et certains autres cancers du sang. Contrairement aux cellules normales, TOUTES les cellules sont incapables de fabriquer leur asparagine. Par conséquent, l'asparaginase empêche les cellules cancéreuses de se diviser et de se développer. L'asparaginase est dérivée d'Escherichia coli, d'Erwinia chrysanthemi, d'asparaginase pégylée, de champignons, d'algues et autres.



Le marché de l'asparaginase mondial est segmenté sur la base du type, de l'application, de l'industrie d'utilisation finale et de la géographie. Par géographie, le marché est largement segmenté en Amérique du Nord, Europe, Asie-Pacifique, Moyen-Orient & Afrique et Sud & Amérique centrale. Ce rapport offre des informations et une analyse approfondie du marché, en mettant l'accent sur des paramètres tels que les tendances et la dynamique du marché, ainsi que sur l'analyse concurrentielle des principaux acteurs du marché mondial.



Insights stratégiques



Régions lucratives pour le marché mondial de l'asparaginase



< span>Régions lucratives pour le marché mondial de l'asparaginase

Informations sur le marché



< span>La croissance significative de l'industrie pharmaceutique et alimentaire stimule le marché mondial de l'asparaginase



L'industrie pharmaceutique et alimentaire s'est considérablement développée et a observé divers développements pour assurer la haute qualité des produits alimentaires et pharmaceutiques . Selon la Fédération européenne des industries et associations pharmaceutiques, l'Amérique du Nord représentait 49 % des ventes pharmaceutiques mondiales en 2021 et 63,7 % des ventes générées par les médicaments nouvellement lancés de 2015 à 2020. De plus, l'industrie pharmaceutique se développe à un rythme important. , soutenue par la montée en puissance des activités de R&D, et une augmentation des investissements dans l'industrie pharmaceutique par les acteurs du marché dynamise davantage le marché.



L'industrie alimentaire est en constante expansion avec une augmentation sans fin de la demande alimentaire. Il y a aussi une augmentation continue des nouveaux produits alimentaires. De nos jours, les fabricants se concentrent sur la quantité nutritionnelle des aliments. La consommation d'aliments frits et cuits au four dans le monde a considérablement augmenté, et l'inclinaison vers ces aliments a également augmenté. L'asparaginase est le principal acide aminé responsable de la réduction du sucre dans les aliments frits et cuits au four condensés avec des sources de carbonyle.



Type Insights



En fonction du type, le marché mondial de l'asparaginase est segmenté en Escherichia coli (E. coli), Erwina Chrysanthemi, Pegylated, et autres. Le segment Escherichia coli détenait une plus grande part du marché en 2021, et ce segment devrait enregistrer le TCAC le plus élevé du marché au cours de la période de prévision 2022-2028, en raison de la demande croissante d'asparaginase dérivée d'E. coli pour le traitement du cancer, comme ALL et LBL.



E dérivé de l'asparaginase . coli est utilisé pour le traitement des leucémies aiguës lymphoblastiques. L'asparaginase E. coli est une enzyme qui catalyse la L-asparagine en acide L-aspartique et en ammoniac. Il aide à la production d'oxaloacétate nécessaire au métabolisme cellulaire. L'asparaginase d'E. coli a une propriété antitumorale qui est utilisée pour le traitement des leucémies. Ainsi, la demande d'asparaginase E. coli pour le traitement du cancer, en particulier chez les patients pédiatriques, stimule la croissance du marché.



Marché mondial de l'asparaginase, par type – 2021 et 2028



Marché mondial de l'asparaginase, par type - 2021 et 2028



Application Insights



Sur la base de l'application, le marché mondial de l'asparaginase est divisé en thérapeutique, transformation alimentaire et autres. Le segment thérapeutique détenait une plus grande part du marché en 2021, et ce segment devrait enregistrer le TCAC le plus élevé du marché en raison de son utilisation dans le traitement des troubles lymphoprolifératifs et des lymphomes. Le segment est ensuite segmenté en leucémie aiguë lymphoblastique, lymphome lymphoblastique et autres.



La leucémie aiguë lymphoblastique est un type de cancer du sang et de la moelle osseuse, qui est mortel lorsqu'il n'est pas traité. Selon l'Institute for Health Metrics and Evaluation, environ 153 000 nouveaux cas et 47 600 décès de leucémie aiguë lymphoblastique ont été signalés dans le monde en 2019. Ainsi, l'augmentation des cas de leucémie aiguë lymphoblastique dans le monde stimule la croissance du marché mondial de l'asparaginase.< /p>

Informations sur l'industrie de l'utilisation finale

Sur la base de l'utilisation finale, le marché mondial de l'asparaginase est segmenté en soins de santé et fabrication alimentaire. Le segment de la santé détenait une plus grande part du marché en 2021. De plus, le même segment devrait enregistrer le TCAC le plus élevé de 2022 à 2028. Le facteur moteur de la croissance de ce segment est l'augmentation de la leucémie lymphoïde aiguë, du lymphome lymphoblastique et de la recherche croissante. activités.



Les stratégies de croissance inorganiques observées sur le marché étaient les fusions et acquisitions, partenariats et collaborations. Ces activités ont ouvert la voie à l'expansion de l'activité et de la clientèle des acteurs du marché. Quelques-uns des développements clés récents du marché sont répertoriés ci-dessous :



  • En mai 2021, Jazz Pharmaceuticals a acquis la société pharmaceutique GW pour renforcer ses capacités de R&D. Cette acquisition aidera également l'entreprise à développer et commercialiser des médicaments sur ordonnance à base de cannabinoïdes.
  • En avril 2021, Servier a finalisé l'acquisition d'Agios Pharmaceuticals’ Plus de 2 milliards de dollars de redevances, y compris un portefeuille d'oncologie commerciale, clinique et de recherche. Cette acquisition renforce la présence commerciale de Servier sur le marché américain de l'hématologie maligne et offre un potentiel de croissance à long terme dans le domaine des tumeurs solides.
  • En août 2018, Medac GmBH, en partenariat avec FarmaMondo SA, distribuera exclusivement Spectrila via un programme d'accès géré pour les soins de santé ciblés Fournisseurs en Russie, en Géorgie, en Azerbaïdjan, au Kirghizistan, en Ouzbékistan et en Moldavie. FarmaMondo gérera l'accès à Spectrila pour les patients atteints de leucémie aiguë lymphoblastique.

Certains des principaux acteurs opérant sur le marché mondial de l'asparaginase comprennent Servier Pharmaceuticals LLC, BioVendor R&D, Creative Enzymes, medac GmbH, Changzhou Qianhong Bio-pharma Co Ltd, United Biotech, Porton Biopharma, Taj Pharmaceuticals Limited et Jazz Pharmaceuticals plc.



Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are Asparaginase?

Asparaginase is an enzyme that breaks down asparagine. Asparaginase is used as a chemotherapy drug to treat acute lymphoblastic leukemia (ALL), lymphoblastic lymphoma (LBL), and certain other blood cancers. Unlike normal cells, ALL cells are unable to make their own asparagine. Therefore, asparaginase stops the cancer cells from dividing and growing. Asparaginase are derived from Escherichia coli, Erwinia chrysanthemi, pegylated asparaginase, fungi, algae and others.

What are the driving factors for the global asparaginase market across the world?

The factors that are driving the growth of the asparaginase market are rising incidences of leukemia and increasing usage applications and significant growth of the pharmaceutical and food industry are the major factors contributing to the growth of the asparaginase industry.

Who are the major players in the asparaginase market across the globe?

The asparaginase market majorly consists of the players, such as Servier Pharmaceuticals LLC, Jazz Pharmaceuticals plc, BioVendor R&D, Creative Enzymes, medac GmbH, Changzhou Qianhong Bio-pharma Co Ltd, United Biotech, Porton Biopharma, and Taj Pharmaceuticals Limited and among others.

What is the market CAGR value of the asparaginase market during the forecast period?

The CAGR value of the asparaginase market during the forecasted period of 2022-2028 is 16.1%

What is the estimated asparaginase market size in 2021?

The asparaginase market is estimated to be valued at US$ 564.01 million in 2021.

What are the growth estimates for the asparaginase market till 2028?

The asparaginase market is expected to be valued at US$ 1,575.62 million in 2028.

Which segment by type led the asparaginase market?

The Escherichia Coli segment held the largest share of the market in the global asparaginase market contributing a market share of 49.78% in 2021.

Which region is projected to be the fastest-growing region in the global asparaginase market?

The Asia Pacific is expected to be the fastest-growing region in the asparaginase market over the forecast period due to increasing prevalence of acute lymphoblastic leukemia, increasing research activities in cancer, and increasing innovative products for treatment of hematological cancers by the market players in the region.

The List of Companies - Asparaginase Market

  1. Servier Pharmaceuticals LLC
  2. Jazz Pharmaceuticals plc
  3. BioVendor R&D
  4. Creative Enzymes
  5. medac GmbH
  6. Changzhou Qianhong Bio-pharma Co Ltd
  7. United Biotech
  8. Porton Biopharma
  9. Taj Pharmaceuticals Limited

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports